SARTORIUS AG · ISIN: DE0007165631 · EQS - Company News

sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow

Göttingen, Germany | October 17, 2024 Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow   Group sales revenue down only slightly by - 2.0 percent after nine months; order intake up 6.6 percent Underlying EBITDA margin reaches 27.7 percent; further increasing positive effects of the efficiency program with highest contribution in the fourth quarter expected Sales revenue of the Bioprocess Solutio...

XETR:SRT3 Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News SARTORIUS AG

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (2)
Short Selling (DE) (1)
Short Selling (UK) (0)
17 October 2024 07:00AM
sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow
DE0007165631
Göttingen, Germany | October 17, 2024 Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow   Group sales revenue down only slightly by - 2.0 percent after nine months; order intake up 6.6 percent Underlying EBITDA margin reaches 27.7 percent; further i...
SARTORIUS AG
About the publication
18 July 2024 06:28PM
Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
DE0007165631
Göttingen, July 18, 2024 Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive   Sales revenue slightly down 2.2 percent after six months; growth of 3.6 percent in second quarter Underlying EBITDA margin at a ...
SARTORIUS AG
About the publication
18 July 2024 06:22PM
Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
DE0007165631
Disclosure of inside information according to Article 17 MAR Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024 In a continuously very challenging and volatile market environment, the life science group Sartorius closed the first half of the year with a positive trend in sales revenue development. In view of t...
SARTORIUS AG
About the publication
More SARTORIUS AG related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 2 23rd July 2024 Kappich, Dr. Lothar Ewald DD
Short Seller (DE) 1 7th December 2017 AQR Capital Management, LLC SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN